Terazosin
NDC 71610-503, Terazosin Hydrochloride, capsule, from Aphena Pharma Solutions - Tennessee, LLC.
- Product NDC
- 71610-503
- Status
- Listed
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA075317
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/71610-503 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TERAZOSIN HYDROCHLORIDE5 mg/1
Pharmacologic classes
Adrenergic alpha-Antagonists [MoA]; alpha-Adrenergic Blocker [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 71610-503-60 | 71610050360 | 90 CAPSULE in 1 BOTTLE (71610-503-60) |
| 71610-503-80 | 71610050380 | 180 CAPSULE in 1 BOTTLE (71610-503-80) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/81d5422c-ff57-4f6d-927c-5de4dd7e1169
Use it
Look up 71610-503 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/71610-503 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 71610-503. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.